Glenmark Life Sciences Limited

BSE:543322 Stock Report

Mkt Cap: ₹47.9b

Glenmark Life Sciences Future Growth

How is Glenmark Life Sciences forecast to perform in the next 1 to 3 years based on estimates from 4 analysts?

Future Growth Score

3/6

Future Growth Score 3/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


15.0%

Forecasted annual earnings growth

Earnings and Revenue Growth Forecasts

BSE:543322 - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
3/31/202526,3835,6863,7085,0173
3/31/202423,2124,7092,1764,3934
3/31/202320,4024,0412,8475,0154
9/30/202220,3574,1821,9913,856N/A
6/30/202220,8824,265N/AN/AN/A
3/31/202221,2324,1874,6545,976N/A
12/31/202120,7634,245N/AN/AN/A
9/30/202120,5414,1424,4435,291N/A
6/30/202120,1313,714N/AN/AN/A
3/31/202118,8523,5163,2013,881N/A
3/31/202015,3733,1311,4381,950N/A
3/31/20198,8641,95610104N/A
3/31/20182-4-5-5N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 543322's forecast earnings growth (15% per year) is above the savings rate (6.8%).

Earnings vs Market: 543322's earnings (15% per year) are forecast to grow slower than the Indian market (19.8% per year).

High Growth Earnings: 543322's earnings are forecast to grow, but not significantly.

Revenue vs Market: 543322's revenue (12.2% per year) is forecast to grow faster than the Indian market (10.6% per year).

High Growth Revenue: 543322's revenue (12.2% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: 543322's Return on Equity is forecast to be high in 3 years time (20.1%)


Discover growth companies